News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
193 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17936)
Month
January (4450)
February (4428)
March (5683)
April (4545)
May (5703)
June (4805)
July (3912)
August (4762)
September (4260)
October (3860)
November (4837)
December (2683)
Day
1 (296)
2 (275)
3 (459)
4 (106)
5 (7)
6 (13)
7 (344)
8 (327)
9 (280)
10 (467)
11 (105)
12 (3)
13 (17)
14 (341)
15 (218)
16 (179)
17 (201)
18 (74)
19 (1)
20 (3)
21 (196)
22 (215)
23 (93)
24 (12)
25 (23)
27 (11)
28 (200)
29 (193)
30 (178)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
27
28
29
30
Business
atai Life Sciences Strengthens Leadership Team with Appointment of Dr. Sahil V. Kirpekar as Chief Business Officer
atai Life Sciences N.V. announced today its appointment of Dr. Kirpekar to serve as the Company’s Chief Business Officer, effective today.
November 29, 2022
·
5 min read
Drug Development
Tyra Biosciences Initiates SURF301 Phase 1/2 Clinical Study and Doses First Patient with TYRA-300
Tyra Biosciences, Inc. today announced the initiation of its SURF301 Phase 1/2 clinical study, with first patient dosed with TYRA-300.
November 29, 2022
·
6 min read
Tetra Bio-Pharma Provides Update on Patent Applications for Novel Therapeutic ARDS-003
Tetra Bio-Pharma Inc. today announced the filing of three patent applications for its novel therapeutic, ARDS-003.
November 29, 2022
·
5 min read
Previous
20 of 20